title: Updating the management of patients with rectal neuroendocrine tumors.
abstract: Rectal neuroendocrine tumors (NETs) account for approximately one-third of all digestive NETs, with an increasing incidence and good overall prognosis. Although recent guidelines have been published, endoscopic techniques have expanded substantially and the most recent reports should be taken into account for clinical practice. The objectives of this report were to review the latest advances on prognosis, pre-interventional explorations, treatment-with particular focus on endoscopy-and surveillance of well-differentiated rectal NETs, excluding poorly differentiated and metastatic tumors.
authors.affiliation: Department of Hepatogastroenterology and Digestive Oncology, University Hospital Robert-Debré, Reims, France.
authors.forename: Louis
authors.initials: L
authors.lastname: de Mestier
authors.forename: Hedia
authors.initials: H
authors.lastname: Brixi
authors.forename: Rodica
authors.initials: R
authors.lastname: Gincul
authors.forename: Thierry
authors.initials: T
authors.lastname: Ponchon
authors.forename: Guillaume
authors.initials: G
authors.lastname: Cadiot
mesh_terms: D003657:Decision Making; D016099:Endoscopy, Gastrointestinal; D019160:Endosonography; D006801:Humans; D018358:Neuroendocrine Tumors / Q000473:pathology* / Q000601:surgery*; D011159:Population Surveillance; D011379:Prognosis; D012004:Rectal Neoplasms / Q000473:pathology* / Q000601:surgery*